Surrozen, Inc. (SRZN)
NASDAQ·Healthcare·Biotechnology
$18.88
-2.96%
Mkt Cap $227.49M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$42.00
Range $40.00 – $44.00
Implied Upside
+122.5%
Consensus $42.00 vs current $18.88
NASDAQ·Healthcare·Biotechnology
$18.88
-2.96%
Mkt Cap $227.49M
No recent rating data.
Price Target (4 analysts)
$42.00
Range $40.00 – $44.00
+122.5%
Consensus $42.00 vs current $18.88